pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·1h ago·1 min read
save

STAT Health Tech newsletter highlights Epic's AI mortality model and Omada's upcoming products

Sep 22, 2026·read at STAT ↗Neutral

The latest STAT Health Tech newsletter edition spotlights two developments in health technology.

It reviews Epic Systems' new mortality prediction algorithm, an artificial intelligence tool designed to assess risk of death among older patients, illustrating how AI is being applied in geriatrics.

The issue also looks ahead to Omada Health's upcoming product pipeline, indicating the company's plans to broaden its digital health offerings.

The piece is authored by Mario Aguilar, a health tech correspondent who covers AI regulation, Medicare payment for tech, and related topics, and it is available to STAT+ subscribers.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Epic’s mortality model, and Omada’s future products”

read at STAT ↗
438 words · retrieved 9m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 1h agoSTAT+: Pharmalittle: We’re reading about pharma seeking to protect China deals, a Roche obesity drug, and moreSTAT
  • 2h agoNew federal autism committee head has financial ties to leucovorinSTAT
  • 6h agoOpinion: The science on relieving cancer symptoms is clear. Why isn’t insurance paying?STAT
  • 6h agoOpinion: Social media bans are passing around the world. How will we know if they help teens?STAT
  • 6h agoSTAT+: Why an influential GOP health policy expert still backs the Medicaid cuts — and which policy target is nextSTAT